Navigation Links
Catabasis Names Ian Sanderson Chief Financial Officer
Date:11/13/2013

CAMBRIDGE, Mass., Nov. 13, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals, Inc., today announced that it has named Ian Sanderson its chief financial officer. Mr. Sanderson brings to Catabasis more than 25 years of experience in life sciences investment research and financial operations.

Prior to joining Catabasis, Mr. Sanderson was a senior adviser at JSB-Partners, L.P., a global life sciences advisory firm specializing in strategic partnering and M&A transactions. Prior to JSB-Partners, Mr. Sanderson was a managing director at Cowen and Company, LLC, where he spent 20 years as an equity research analyst covering the specialty pharmaceuticals, pharmaceuticals and medical technology sectors. Mr. Sanderson began his life sciences career in healthcare investment banking at Cowen and Company and at Houlihan Lokey Howard and Zukin, and in financial operations at U.S. Surgical Corporation (now Covidien). Mr. Sanderson also served as a director of development-stage, drug delivery technology company Spherics, Inc., advising on strategic and product development.

"Ian's decades of experience as an advisor and financial analyst and his extensive network of relationships in the life sciences financial community make him an excellent addition to the Catabasis team as the company progresses toward important milestones such as top-line Phase 2 data for our lead compound, CAT-2003," said Jill Milne, Ph.D., co-founder and chief executive officer of Catabasis.

Mr. Sanderson holds a bachelor's degree in political economics from Williams College and an MBA in finance from the University of Pennsylvania.

About CatabasisCatabasis is a clinical-stage company dedicated to the discovery and development of innovative medicines to treat inflammatory and metabolic diseases. The company's drug development programs are rooted in the principles of pathway pharmacology, the treatment of diseases by simultaneously modulating more than one target in a disease pathway. Using its proprietary SMART Linker technology, the company conjugates two drugs that act on different components of a disease pathway with the goal of producing new chemical entities with significantly enhanced efficacy and improved safety and tolerability profiles. The company has assembled a team of passionate and experienced scientists who are committed to improving the lives of patients. The company was founded in 2008 and is headquartered in Cambridge, Mass.

Please visit www.catabasis.com for more information.Media ContactsCorporate ContactTony Russo, Ph.D.Amy LynchMatt Middleman, M.D.Catabasis Pharmaceuticals, Inc.Russo PartnersT: (617)-349-1971T: 212-845-425alynch@catabasis.comT: 212-845-4272tony.russo@russopartnersllc.commatt.middleman@russopartnersllc.com
'/>"/>

SOURCE Catabasis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series
2. Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia
3. Imprimis Pharmaceutical Names Seasoned Ophthalmology Executive John Saharek as Vice-President of Commercialization for its Ophthalmology Division
4. Accelerate Diagnostics, Inc. Names Mark C. Miller to Board of Directors
5. 2013 ISPE Facility of the Year Awards Program Names Novartiss United States Flu Cell Culture Facility as Overall Winner
6. Pharmacy Technician Certification Board Names Linda Henson and Rico Powell as 2013 PTCB CPhT of the Year Finalists
7. Pharmacy Technician Certification Board Names Master Sergeant Jessica Hughes the 2013 PTCB CPhT of the Year
8. Aratana Therapeutics names Wendy Yarno to its Board of Directors
9. CIVCO Names Darrell Newcombe as Vice President of International Sales for Radiation Oncology
10. Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
11. ImmusanT Names Ferdinand E. Massari as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life Agency ... Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... 19, 2017 , ... Peter Chandonait, Abt Associates Principal Scientist ... (PMI) Africa Indoor Residual Spraying (AIRS) Project , has been named the Grand ... Action Award, a USAID Catalyst Award, recognizes USAID staff and implementing partners who ...
(Date:9/19/2017)... ... September 19, 2017 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... part of its national Swirl: A Wine Tasting Event series on Thursday, October ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... the addition of Canyon Ranch to its recently formed Corporate Roundtable, ... a sustainable healthcare system and a sustainable world. , Canyon Ranch is a ...
(Date:9/19/2017)... New York, NY (PRWEB) , ... September 19, ... ... Podiatry (ABMSP) has issued a rallying cry to Americans to watch for the ... late summer. From young athletes to senior citizens, everyone is at risk for ...
(Date:9/19/2017)... LEE, N.J. (PRWEB) , ... September 19, 2017 , ... ... the Subperiosteal Implant: Volume II ” (published by Xlibris on July of 2014). This ... and reviews conventional and new methodological approaches that benefit people who have lost all ...
Breaking Medicine News(10 mins):